Clinical Trials

Neurogene Shares Key Information on Gene Therapy Clinical Trial with the Rett Community

What Wearables and AI Can Tell Us About Rett Syndrome Severity

Taysha Provides Update For Their Rett Syndrome Gene Replacement Program

Neurogene Receives FDA Approval for Gene Replacement Clinical Trial for Rett Syndrome

The Story Behind Mini-MeCP2

What We Accomplished in 2022

What We Learned from Taysha’s Clinical Trial Community Update

Taysha Gene Therapies Shares Rett Syndrome Community Statement on its Collaboration with Astellas Gene Therapies

Taysha Announces Collaboration with Astellas Gene Therapies

Taysha Gene Therapies Shares Rett Syndrome Community Statement on its Clinical Trial

Many ways to participate in the public meeting with the FDA on March 11

Outcomes of a Marathon FDA Meeting on the Safety of Gene Replacement

Seven New RSRT-Supported Therapeutics Make Their Way Towards Clinical Trials

Assessing Rett Symptoms with Cutting Edge Biosensors and Invisible Technology

Imagine Revolutionizing Your Child’s Clinical Care – Introducing the Rett Syndrome Global Registry

Biomarkers - What are they and why do we need them?

New Drugs Restore Brain Balance to Treat Rett Syndrome

Ketamine Clinical Trial for Rett Syndrome Launches